India · Delayed Price · Currency is INR GKB Ophthalmics Statistics
Total Valuation
GKB Ophthalmics has a market cap or net worth of INR 390.24 million. The enterprise value is 449.81 million.
| Market Cap | 390.24M |
| Enterprise Value | 449.81M |
Important Dates
The last earnings date was Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GKB Ophthalmics has 5.04 million shares outstanding. The number of shares has decreased by -0.35% in one year.
| Current Share Class | 5.04M |
| Shares Outstanding | 5.04M |
| Shares Change (YoY) | -0.35% |
| Shares Change (QoQ) | -0.07% |
| Owned by Insiders (%) | 72.25% |
| Owned by Institutions (%) | 5.51% |
| Float | 1.16M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.34 |
| PB Ratio | 0.69 |
| P/TBV Ratio | 0.75 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.76 |
| EV / Sales | 0.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.53 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | -5.38% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 6.78M |
| Profits Per Employee | -459,371 |
| Employee Count | 170 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, GKB Ophthalmics has paid 3.75 million in taxes.
| Income Tax | 3.75M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -35.84% in the last 52 weeks. The beta is 0.37, so GKB Ophthalmics's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | -35.84% |
| 50-Day Moving Average | 76.45 |
| 200-Day Moving Average | 82.44 |
| Relative Strength Index (RSI) | 48.96 |
| Average Volume (20 Days) | 5,052 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GKB Ophthalmics had revenue of INR 1.15 billion and -78.09 million in losses. Loss per share was -15.52.
| Revenue | 1.15B |
| Gross Profit | 366.32M |
| Operating Income | -63.09M |
| Pretax Income | -74.50M |
| Net Income | -78.09M |
| EBITDA | -31.76M |
| EBIT | -63.09M |
| Loss Per Share | -15.52 |
Balance Sheet
The company has 129.37 million in cash and 144.96 million in debt, giving a net cash position of -15.59 million or -3.09 per share.
| Cash & Cash Equivalents | 129.37M |
| Total Debt | 144.96M |
| Net Cash | -15.59M |
| Net Cash Per Share | -3.09 |
| Equity (Book Value) | 564.37M |
| Book Value Per Share | 103.24 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 31.78%, with operating and profit margins of -5.47% and -6.77%.
| Gross Margin | 31.78% |
| Operating Margin | -5.47% |
| Pretax Margin | -6.46% |
| Profit Margin | -6.77% |
| EBITDA Margin | -2.76% |
| EBIT Margin | -5.47% |
| FCF Margin | n/a |
Dividends & Yields
GKB Ophthalmics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.35% |
| Shareholder Yield | n/a |
| Earnings Yield | -20.01% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |